I agree that this site is using cookies. You can find further informations here.
X
Goy, Andre
789  results:
Search for persons X
?
1

Bridging therapy with axicabtagene ciloleucel for large B-c..:

Jain, Michael D. ; Jacobs, Miriam T. ; Gao, Feng...
Blood Advances.  8 (2024)  4 - p. 1042-1050 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Toxicity and efficacy of CAR T-cell therapy in primary and ..:

Cook, Michael R. ; Dorris, C. Scott ; Makambi, Kepher H....
Blood Advances.  7 (2023)  1 - p. 32-39 , 2023
Link: https://doi.org/10.1182/..
 
?
3

Combining cell-free RNA with cell-free DNA in liquid biopsy..:

Albitar, Maher ; Zhang, Hong ; Charifa, Ahmad...
Heliyon.  9 (2023)  5 - p. e16261 , 2023
Link: https://doi.org/10.1016/..
 
?
4

The iR2 regimen (ibrutinib plus lenalidomide and rituximab)..:

Ramchandren, Radhakrishnan ; Johnson, Peter ; Ghosh, Nilanjan...
eClinicalMedicine.  56 (2023)  - p. 101779 , 2023
Link: https://doi.org/10.1016/..
 
?
5

The use of transcriptomic data in developing biomarkers in ..:

Albitar, Maher ; Goy, Andre ; Pecora, Andrew...
ImmunoMedicine.  4 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
6

Final results and overall survival data from a phase II stu..:

Le Gouill, Steven ; Długosz-Danecka, Monika ; Rule, Simon...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
7

Homologous Recombination Abnormalities Associated With BRCA..:

Albitar, Maher ; Zhang, Hong ; Pecora, Andrew...
Breast Cancer: Basic and Clinical Research.  17 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
8

5-Year Follow-Up Supports Curative Potential of Axicabtagen..:

Neelapu, Sattva S. ; Jacobson, Caron A. ; Ghobadi, Armin...
Blood.  , 2023
Link: https://doi.org/10.1182/..
 
?
9

Differential Diagnosis of Hematologic and Solid Tumors Usin..:

Zhang, Hong ; Qureshi, Muhammad A. ; Wahid, Mohsin...
The American Journal of Pathology.  193 (2023)  1 - p. 51-59 , 2023
Link: https://doi.org/10.1016/..
 
?
10

A phase II study of interrupted and continuous dose lenalid..:

Fehniger, Todd A. ; Watkins, Marcus P. ; Ezenwajiaku, Nkiruka...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
11

Determining clinical course of diffuse large B-cell lymphom..:

Albitar, Maher ; Zhang, Hong ; Goy, Andre...
Blood Cancer Journal.  12 (2022)  2 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
12

Long-term Outcomes With Ibrutinib Treatment for Patients Wi..:

Dreyling, Martin ; Goy, Andre ; Hess, Georg...
HemaSphere.  6 (2022)  5 - p. e712 , 2022
Link: https://doi.org/10.1097/..
 
?
13

Phase 1b Dose-finding Study of Venetoclax With Ibrutinib an..:

Petrillo, Alessandra ; Ip, Andrew ; Della Pia, Alexandra...
HemaSphere.  6 (2022)  6 - p. e719 , 2022
Link: https://doi.org/10.1097/..
 
?
14

Venetoclax retreatment of patients with chronic lymphocytic..:

Thompson, Meghan C. ; Harrup, Rosemary A. ; Coombs, Catherine C....
Blood Advances.  6 (2022)  15 - p. 4553-4557 , 2022
Link: https://doi.org/10.1182/..
 
?
15

Effect of Prior Therapy and Disease Refractoriness on the E..:

Schuster, Michael ; Zijlstra, Josée ; Casasnovas, Rene-Olivier...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  7 - p. 483-494 , 2022
Link: https://doi.org/10.1016/..
 
1-15